Stem cell therapies in reparative medicine

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The future implementation of stem cell therapies to treat conditions thus far considered incurable has been envisioned as logical consequence of the fast-paced progress in stem cell research over the last few years. Still, many practical obstacles stand in the way to the routine application of these novel technologies in medicine. The conference "Stem Cell Therapies in Reparative Medicine," held aboard the cruise vessel Majesty of the Seas (Miami, USA- Nassau, Bahamas, April 19-22, 2002), focused on the analysis of these problems from different perspectives, including developmental biology (cell proliferation, fate determination, and enrichment), immunology (allorejection and prevention of autoimmunity recurrence), and clinical therapy, emphasizing the impact of stem cell technologies on the emerging field of tissue engineering and the treatment of alpha-1 antitrypsin deficiency.

Original languageEnglish
Pages (from-to)329-334
Number of pages6
JournalCell Transplantation
Volume12
Issue number4
StatePublished - Aug 8 2003

Fingerprint

Cell- and Tissue-Based Therapy
Stem cells
Medicine
Stem Cells
Bahamas
alpha 1-Antitrypsin Deficiency
Technology
Stem Cell Research
Developmental Biology
Immunology
Tissue Engineering
Allergy and Immunology
Autoimmunity
Oceans and Seas
Cell proliferation
Tissue engineering
Cell Proliferation
Recurrence
Therapeutics

Keywords

  • Alpha-1 antitrypsin
  • Development
  • Diabetes
  • Human embryonic stem cells
  • Mesenchymal stem cells

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation

Cite this

Stem cell therapies in reparative medicine. / Dominguez-Bendala, Juan; Ricordi, Camillo.

In: Cell Transplantation, Vol. 12, No. 4, 08.08.2003, p. 329-334.

Research output: Contribution to journalArticle

@article{e6cd76112d694cae86a7ee2064b62f6a,
title = "Stem cell therapies in reparative medicine",
abstract = "The future implementation of stem cell therapies to treat conditions thus far considered incurable has been envisioned as logical consequence of the fast-paced progress in stem cell research over the last few years. Still, many practical obstacles stand in the way to the routine application of these novel technologies in medicine. The conference {"}Stem Cell Therapies in Reparative Medicine,{"} held aboard the cruise vessel Majesty of the Seas (Miami, USA- Nassau, Bahamas, April 19-22, 2002), focused on the analysis of these problems from different perspectives, including developmental biology (cell proliferation, fate determination, and enrichment), immunology (allorejection and prevention of autoimmunity recurrence), and clinical therapy, emphasizing the impact of stem cell technologies on the emerging field of tissue engineering and the treatment of alpha-1 antitrypsin deficiency.",
keywords = "Alpha-1 antitrypsin, Development, Diabetes, Human embryonic stem cells, Mesenchymal stem cells",
author = "Juan Dominguez-Bendala and Camillo Ricordi",
year = "2003",
month = "8",
day = "8",
language = "English",
volume = "12",
pages = "329--334",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "4",

}

TY - JOUR

T1 - Stem cell therapies in reparative medicine

AU - Dominguez-Bendala, Juan

AU - Ricordi, Camillo

PY - 2003/8/8

Y1 - 2003/8/8

N2 - The future implementation of stem cell therapies to treat conditions thus far considered incurable has been envisioned as logical consequence of the fast-paced progress in stem cell research over the last few years. Still, many practical obstacles stand in the way to the routine application of these novel technologies in medicine. The conference "Stem Cell Therapies in Reparative Medicine," held aboard the cruise vessel Majesty of the Seas (Miami, USA- Nassau, Bahamas, April 19-22, 2002), focused on the analysis of these problems from different perspectives, including developmental biology (cell proliferation, fate determination, and enrichment), immunology (allorejection and prevention of autoimmunity recurrence), and clinical therapy, emphasizing the impact of stem cell technologies on the emerging field of tissue engineering and the treatment of alpha-1 antitrypsin deficiency.

AB - The future implementation of stem cell therapies to treat conditions thus far considered incurable has been envisioned as logical consequence of the fast-paced progress in stem cell research over the last few years. Still, many practical obstacles stand in the way to the routine application of these novel technologies in medicine. The conference "Stem Cell Therapies in Reparative Medicine," held aboard the cruise vessel Majesty of the Seas (Miami, USA- Nassau, Bahamas, April 19-22, 2002), focused on the analysis of these problems from different perspectives, including developmental biology (cell proliferation, fate determination, and enrichment), immunology (allorejection and prevention of autoimmunity recurrence), and clinical therapy, emphasizing the impact of stem cell technologies on the emerging field of tissue engineering and the treatment of alpha-1 antitrypsin deficiency.

KW - Alpha-1 antitrypsin

KW - Development

KW - Diabetes

KW - Human embryonic stem cells

KW - Mesenchymal stem cells

UR - http://www.scopus.com/inward/record.url?scp=0041707890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041707890&partnerID=8YFLogxK

M3 - Article

C2 - 12911121

AN - SCOPUS:0041707890

VL - 12

SP - 329

EP - 334

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 4

ER -